Dr David Chang
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
26 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Survival and patterns of failure in small cell neuroendocrine carcinoma of the cervix treated with definitive chemoradiotherapy
DOI: 10.1016/j.ijgc.2025.1028742025
Journal article
Impact of the R.E.N.A.L. complexity score on outcomes of stereotactic ablative body radiotherapy for primary renal cell carcinoma
DOI: 10.1111/bju.168432025
Journal article
A population-based analyses of the evolving management of cN1M0 prostate cancer in the PSMA-PET era
DOI: 10.1002/bco2.700592025
Journal article
PSMA-Guided Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma: The Proof-of-Concept PEDESTAL Study
DOI: 10.2967/jnumed.124.2686392024
Conference Proceedings
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer
DOI: 10.1016/j.euo.2024.03.0102024
Research grants (other domestic)
Stereotactic Ablative Body Radiotherapy (SABR) for 4 Gynaecologic Metastases
2024
Journal article
Automated lattice radiation therapy treatment planning personalised to tumour size and shape
DOI: 10.1016/j.ejmp.2024.104490
RECENT SCHOLARLY WORKS
2024
Journal article
Partially Ablative Body Radiotherapy (PABR): A novel approach for palliative radiotherapy of locally advanced bulky unresectable sarcomas
DOI: 10.1016/j.radonc.2024.1102752024
Journal article
Partially Ablative Body Radiotherapy (PABR): A novel approach for palliative radiotherapy of locally advanced bulky unresectable sarcomas
DOI: 10.1016/j.radonc.2024.1101852024
Conference Proceedings
Partially Ablative Body Radiotherapy (PABR): A novel approach for unresectable sarcomas
DOI: 10.1016/s0167-8140(24)02421-62024
Journal article
SABR for oligometastatic renal cell carcinoma.
DOI: 10.1016/j.ctro.2024.100739